nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—JUN—Vinblastine—germ cell cancer	0.504	0.667	CbGbCtD
Irbesartan—PTGS1—Ifosfamide—germ cell cancer	0.066	0.0874	CbGbCtD
Irbesartan—CYP2C8—Ifosfamide—germ cell cancer	0.0381	0.0505	CbGbCtD
Irbesartan—PTGS1—Etoposide—germ cell cancer	0.0316	0.0418	CbGbCtD
Irbesartan—CYP2C9—Ifosfamide—germ cell cancer	0.0266	0.0352	CbGbCtD
Irbesartan—CYP2C8—Etoposide—germ cell cancer	0.0182	0.0241	CbGbCtD
Irbesartan—CYP3A4—Ifosfamide—germ cell cancer	0.0155	0.0205	CbGbCtD
Irbesartan—CYP1A2—Etoposide—germ cell cancer	0.0141	0.0187	CbGbCtD
Irbesartan—CYP2C9—Cisplatin—germ cell cancer	0.0129	0.0171	CbGbCtD
Irbesartan—CYP2D6—Vinblastine—germ cell cancer	0.0129	0.0171	CbGbCtD
Irbesartan—JUN—adrenal medulla—germ cell cancer	0.0117	0.132	CbGeAlD
Irbesartan—CYP3A4—Vinblastine—germ cell cancer	0.0082	0.0109	CbGbCtD
Irbesartan—CYP3A4—Etoposide—germ cell cancer	0.00738	0.00978	CbGbCtD
Irbesartan—CYP2C9—cardial valve—germ cell cancer	0.00717	0.0806	CbGeAlD
Irbesartan—JUN—skin epidermis—germ cell cancer	0.00345	0.0388	CbGeAlD
Irbesartan—JUN—ganglion—germ cell cancer	0.0029	0.0327	CbGeAlD
Irbesartan—JUN—endothelium—germ cell cancer	0.0025	0.0282	CbGeAlD
Irbesartan—JUN—blood vessel—germ cell cancer	0.00231	0.026	CbGeAlD
Irbesartan—AGTR1—endothelium—germ cell cancer	0.00189	0.0212	CbGeAlD
Irbesartan—AGTR1—blood vessel—germ cell cancer	0.00174	0.0196	CbGeAlD
Irbesartan—JUN—neck—germ cell cancer	0.00165	0.0186	CbGeAlD
Irbesartan—CYP1A2—urine—germ cell cancer	0.00163	0.0183	CbGeAlD
Irbesartan—EDNRA—trigeminal ganglion—germ cell cancer	0.00156	0.0176	CbGeAlD
Irbesartan—CYP2C9—urine—germ cell cancer	0.00155	0.0174	CbGeAlD
Irbesartan—JUN—trigeminal ganglion—germ cell cancer	0.00143	0.0161	CbGeAlD
Irbesartan—JUN—embryo—germ cell cancer	0.00138	0.0155	CbGeAlD
Irbesartan—JUN—brainstem—germ cell cancer	0.00126	0.0142	CbGeAlD
Irbesartan—UGT1A3—endocrine gland—germ cell cancer	0.00125	0.014	CbGeAlD
Irbesartan—AGTR1—neck—germ cell cancer	0.00124	0.014	CbGeAlD
Irbesartan—JUN—eye—germ cell cancer	0.00123	0.0138	CbGeAlD
Irbesartan—JUN—retina—germ cell cancer	0.00122	0.0137	CbGeAlD
Irbesartan—CYP3A4—urine—germ cell cancer	0.00118	0.0133	CbGeAlD
Irbesartan—EDNRA—decidua—germ cell cancer	0.00116	0.0131	CbGeAlD
Irbesartan—CYP2D6—urine—germ cell cancer	0.00116	0.013	CbGeAlD
Irbesartan—UGT1A3—Metapathway biotransformation—NAT9—germ cell cancer	0.00114	0.0447	CbGpPWpGaD
Irbesartan—JUN—telencephalon—germ cell cancer	0.00112	0.0126	CbGeAlD
Irbesartan—JUN—Regulation of Androgen receptor activity—NR0B1—germ cell cancer	0.0011	0.043	CbGpPWpGaD
Irbesartan—JUN—skin of body—germ cell cancer	0.00107	0.012	CbGeAlD
Irbesartan—JUN—decidua—germ cell cancer	0.00106	0.0119	CbGeAlD
Irbesartan—EDNRA—uterus—germ cell cancer	0.00102	0.0115	CbGeAlD
Irbesartan—EDNRA—pituitary gland—germ cell cancer	0.001	0.0112	CbGeAlD
Irbesartan—EDNRA—medulla oblongata—germ cell cancer	0.000965	0.0109	CbGeAlD
Irbesartan—PTGS1—ganglion—germ cell cancer	0.000962	0.0108	CbGeAlD
Irbesartan—JUN—Validated nuclear estrogen receptor alpha network—NR0B1—germ cell cancer	0.000943	0.037	CbGpPWpGaD
Irbesartan—JUN—gonad—germ cell cancer	0.000935	0.0105	CbGeAlD
Irbesartan—JUN—uterus—germ cell cancer	0.000929	0.0105	CbGeAlD
Irbesartan—JUN—pituitary gland—germ cell cancer	0.000912	0.0103	CbGeAlD
Irbesartan—EDNRA—adrenal gland—germ cell cancer	0.000893	0.01	CbGeAlD
Irbesartan—EDNRA—midbrain—germ cell cancer	0.000882	0.00992	CbGeAlD
Irbesartan—JUN—medulla oblongata—germ cell cancer	0.00088	0.0099	CbGeAlD
Irbesartan—EDNRA—female gonad—germ cell cancer	0.000833	0.00937	CbGeAlD
Irbesartan—PTGS1—endothelium—germ cell cancer	0.000829	0.00933	CbGeAlD
Irbesartan—JUN—adrenal gland—germ cell cancer	0.000815	0.00917	CbGeAlD
Irbesartan—JUN—Oxidative Stress Induced Senescence—PHC1—germ cell cancer	0.000806	0.0316	CbGpPWpGaD
Irbesartan—JUN—midbrain—germ cell cancer	0.000805	0.00905	CbGeAlD
Irbesartan—AGTR1—decidua—germ cell cancer	0.0008	0.009	CbGeAlD
Irbesartan—JUN—bone marrow—germ cell cancer	0.000788	0.00887	CbGeAlD
Irbesartan—JUN—spinal cord—germ cell cancer	0.000785	0.00883	CbGeAlD
Irbesartan—PTGS1—blood vessel—germ cell cancer	0.000765	0.0086	CbGeAlD
Irbesartan—JUN—female gonad—germ cell cancer	0.00076	0.00855	CbGeAlD
Irbesartan—EDNRA—testis—germ cell cancer	0.000739	0.00831	CbGeAlD
Irbesartan—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—SALL4—germ cell cancer	0.000714	0.028	CbGpPWpGaD
Irbesartan—JUN—endocrine gland—germ cell cancer	0.000707	0.00795	CbGeAlD
Irbesartan—JUN—head—germ cell cancer	0.000698	0.00785	CbGeAlD
Irbesartan—AGTR1—pituitary gland—germ cell cancer	0.000687	0.00773	CbGeAlD
Irbesartan—JUN—testis—germ cell cancer	0.000674	0.00758	CbGeAlD
Irbesartan—AGTR1—medulla oblongata—germ cell cancer	0.000663	0.00746	CbGeAlD
Irbesartan—EDNRA—EGFR-dependent Endothelin signaling events—HRAS—germ cell cancer	0.000636	0.025	CbGpPWpGaD
Irbesartan—JUN—cerebellum—germ cell cancer	0.000622	0.007	CbGeAlD
Irbesartan—AGTR1—adrenal gland—germ cell cancer	0.000614	0.0069	CbGeAlD
Irbesartan—JUN—Cellular Senescence—PHC1—germ cell cancer	0.000564	0.0221	CbGpPWpGaD
Irbesartan—JUN—Wnt Signaling Pathway and Pluripotency—NANOG—germ cell cancer	0.000563	0.0221	CbGpPWpGaD
Irbesartan—EDNRA—brain—germ cell cancer	0.000554	0.00623	CbGeAlD
Irbesartan—JUN—Wnt Signaling Pathway and Pluripotency—POU5F1—germ cell cancer	0.000542	0.0213	CbGpPWpGaD
Irbesartan—EDNRA—lymph node—germ cell cancer	0.000535	0.00602	CbGeAlD
Irbesartan—AGTR1—endocrine gland—germ cell cancer	0.000532	0.00599	CbGeAlD
Irbesartan—AGTR1—head—germ cell cancer	0.000525	0.00591	CbGeAlD
Irbesartan—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—KLF4—germ cell cancer	0.000518	0.0203	CbGpPWpGaD
Irbesartan—AGTR1—testis—germ cell cancer	0.000508	0.00571	CbGeAlD
Irbesartan—JUN—brain—germ cell cancer	0.000506	0.00569	CbGeAlD
Irbesartan—JUN—lymph node—germ cell cancer	0.000489	0.0055	CbGeAlD
Irbesartan—JUN—Cellular responses to stress—PHC1—germ cell cancer	0.000426	0.0167	CbGpPWpGaD
Irbesartan—CYP2C8—Metapathway biotransformation—NAT9—germ cell cancer	0.000414	0.0162	CbGpPWpGaD
Irbesartan—JUN—AGE/RAGE pathway—ALPL—germ cell cancer	0.000413	0.0162	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000401	0.0157	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000386	0.0151	CbGpPWpGaD
Irbesartan—AGTR1—brain—germ cell cancer	0.000381	0.00428	CbGeAlD
Irbesartan—CYP2C8—pituitary gland—germ cell cancer	0.000372	0.00419	CbGeAlD
Irbesartan—PTGS1—telencephalon—germ cell cancer	0.000371	0.00417	CbGeAlD
Irbesartan—AGTR1—lymph node—germ cell cancer	0.000368	0.00414	CbGeAlD
Irbesartan—UGT1A3—NRF2 pathway—SLC2A3—germ cell cancer	0.000358	0.014	CbGpPWpGaD
Irbesartan—PTGS1—skin of body—germ cell cancer	0.000354	0.00398	CbGeAlD
Irbesartan—CYP2D6—brainstem—germ cell cancer	0.000344	0.00387	CbGeAlD
Irbesartan—CYP2D6—Metapathway biotransformation—NAT9—germ cell cancer	0.00034	0.0133	CbGpPWpGaD
Irbesartan—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	0.000337	0.0132	CbGpPWpGaD
Irbesartan—PTGS1—uterus—germ cell cancer	0.000308	0.00346	CbGeAlD
Irbesartan—CYP2D6—telencephalon—germ cell cancer	0.000305	0.00343	CbGeAlD
Irbesartan—PTGS1—pituitary gland—germ cell cancer	0.000302	0.0034	CbGeAlD
Irbesartan—JUN—Wnt Signaling Pathway and Pluripotency—SOX2—germ cell cancer	0.000301	0.0118	CbGpPWpGaD
Irbesartan—CYP2C8—endocrine gland—germ cell cancer	0.000289	0.00325	CbGeAlD
Irbesartan—CYP1A2—Metapathway biotransformation—NAT9—germ cell cancer	0.000288	0.0113	CbGpPWpGaD
Irbesartan—CYP2C8—testis—germ cell cancer	0.000275	0.0031	CbGeAlD
Irbesartan—EDNRA—G alpha (q) signalling events—OXT—germ cell cancer	0.000272	0.0107	CbGpPWpGaD
Irbesartan—CYP1A2—endocrine gland—germ cell cancer	0.00027	0.00304	CbGeAlD
Irbesartan—PTGS1—adrenal gland—germ cell cancer	0.00027	0.00304	CbGeAlD
Irbesartan—EDNRA—Peptide ligand-binding receptors—OXT—germ cell cancer	0.000268	0.0105	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—FGF4—germ cell cancer	0.000268	0.0105	CbGpPWpGaD
Irbesartan—PTGS1—spinal cord—germ cell cancer	0.00026	0.00292	CbGeAlD
Irbesartan—Photosensitivity—Methotrexate—germ cell cancer	0.000258	0.00198	CcSEcCtD
Irbesartan—Immune system disorder—Cisplatin—germ cell cancer	0.000258	0.00198	CcSEcCtD
Irbesartan—Abdominal pain—Vinblastine—germ cell cancer	0.000258	0.00198	CcSEcCtD
Irbesartan—Mediastinal disorder—Cisplatin—germ cell cancer	0.000257	0.00197	CcSEcCtD
Irbesartan—Hypotension—Bleomycin—germ cell cancer	0.000257	0.00197	CcSEcCtD
Irbesartan—Oedema—Dactinomycin—germ cell cancer	0.000257	0.00197	CcSEcCtD
Irbesartan—Urethral disorder—Etoposide—germ cell cancer	0.000257	0.00197	CcSEcCtD
Irbesartan—CYP2C9—endocrine gland—germ cell cancer	0.000256	0.00288	CbGeAlD
Irbesartan—Infection—Dactinomycin—germ cell cancer	0.000255	0.00196	CcSEcCtD
Irbesartan—Arrhythmia—Cisplatin—germ cell cancer	0.000255	0.00196	CcSEcCtD
Irbesartan—Cough—Ifosfamide—germ cell cancer	0.000252	0.00193	CcSEcCtD
Irbesartan—PTGS1—female gonad—germ cell cancer	0.000252	0.00283	CbGeAlD
Irbesartan—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000252	0.00193	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000251	0.00192	CcSEcCtD
Irbesartan—Hypertension—Ifosfamide—germ cell cancer	0.000249	0.00191	CcSEcCtD
Irbesartan—Erythema—Cisplatin—germ cell cancer	0.000249	0.00191	CcSEcCtD
Irbesartan—Malnutrition—Cisplatin—germ cell cancer	0.000249	0.00191	CcSEcCtD
Irbesartan—Paraesthesia—Bleomycin—germ cell cancer	0.000247	0.0019	CcSEcCtD
Irbesartan—Dyspnoea—Bleomycin—germ cell cancer	0.000246	0.00188	CcSEcCtD
Irbesartan—Chest pain—Ifosfamide—germ cell cancer	0.000246	0.00188	CcSEcCtD
Irbesartan—Myalgia—Ifosfamide—germ cell cancer	0.000246	0.00188	CcSEcCtD
Irbesartan—Arthralgia—Ifosfamide—germ cell cancer	0.000246	0.00188	CcSEcCtD
Irbesartan—Flatulence—Cisplatin—germ cell cancer	0.000245	0.00188	CcSEcCtD
Irbesartan—Anorexia—Dactinomycin—germ cell cancer	0.000245	0.00188	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000244	0.00187	CcSEcCtD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	0.000243	0.00953	CbGpPWpGaD
Irbesartan—Cardiac disorder—Etoposide—germ cell cancer	0.000243	0.00186	CcSEcCtD
Irbesartan—Flushing—Etoposide—germ cell cancer	0.000243	0.00186	CcSEcCtD
Irbesartan—Discomfort—Ifosfamide—germ cell cancer	0.000243	0.00186	CcSEcCtD
Irbesartan—Hypersensitivity—Vinblastine—germ cell cancer	0.00024	0.00184	CcSEcCtD
Irbesartan—Decreased appetite—Bleomycin—germ cell cancer	0.000239	0.00184	CcSEcCtD
Irbesartan—Visual disturbance—Methotrexate—germ cell cancer	0.000239	0.00183	CcSEcCtD
Irbesartan—Muscle spasms—Cisplatin—germ cell cancer	0.000239	0.00183	CcSEcCtD
Irbesartan—Angiopathy—Etoposide—germ cell cancer	0.000237	0.00182	CcSEcCtD
Irbesartan—Immune system disorder—Etoposide—germ cell cancer	0.000236	0.00181	CcSEcCtD
Irbesartan—Mediastinal disorder—Etoposide—germ cell cancer	0.000236	0.00181	CcSEcCtD
Irbesartan—Pain—Bleomycin—germ cell cancer	0.000236	0.00181	CcSEcCtD
Irbesartan—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000235	0.0018	CcSEcCtD
Irbesartan—Oedema—Ifosfamide—germ cell cancer	0.000235	0.0018	CcSEcCtD
Irbesartan—Chills—Etoposide—germ cell cancer	0.000235	0.0018	CcSEcCtD
Irbesartan—Vision blurred—Cisplatin—germ cell cancer	0.000234	0.0018	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000234	0.00179	CcSEcCtD
Irbesartan—Asthenia—Vinblastine—germ cell cancer	0.000234	0.00179	CcSEcCtD
Irbesartan—PTGS1—endocrine gland—germ cell cancer	0.000234	0.00263	CbGeAlD
Irbesartan—Infection—Ifosfamide—germ cell cancer	0.000234	0.00179	CcSEcCtD
Irbesartan—Tremor—Cisplatin—germ cell cancer	0.000233	0.00179	CcSEcCtD
Irbesartan—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000231	0.00177	CcSEcCtD
Irbesartan—PTGS1—head—germ cell cancer	0.000231	0.0026	CbGeAlD
Irbesartan—Nervous system disorder—Ifosfamide—germ cell cancer	0.000231	0.00177	CcSEcCtD
Irbesartan—Ill-defined disorder—Cisplatin—germ cell cancer	0.000231	0.00177	CcSEcCtD
Irbesartan—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000231	0.00177	CcSEcCtD
Irbesartan—Anaemia—Cisplatin—germ cell cancer	0.00023	0.00176	CcSEcCtD
Irbesartan—Skin disorder—Ifosfamide—germ cell cancer	0.000229	0.00175	CcSEcCtD
Irbesartan—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000228	0.00174	CcSEcCtD
Irbesartan—Feeling abnormal—Bleomycin—germ cell cancer	0.000227	0.00174	CcSEcCtD
Irbesartan—Anorexia—Ifosfamide—germ cell cancer	0.000224	0.00172	CcSEcCtD
Irbesartan—Malaise—Cisplatin—germ cell cancer	0.000224	0.00172	CcSEcCtD
Irbesartan—JUN—FGF signaling pathway—FGFR3—germ cell cancer	0.000224	0.00879	CbGpPWpGaD
Irbesartan—Decreased appetite—Dactinomycin—germ cell cancer	0.000223	0.00171	CcSEcCtD
Irbesartan—Diarrhoea—Vinblastine—germ cell cancer	0.000223	0.00171	CcSEcCtD
Irbesartan—PTGS1—testis—germ cell cancer	0.000223	0.00251	CbGeAlD
Irbesartan—Dysgeusia—Etoposide—germ cell cancer	0.000223	0.00171	CcSEcCtD
Irbesartan—Leukopenia—Cisplatin—germ cell cancer	0.000223	0.00171	CcSEcCtD
Irbesartan—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.000222	0.00872	CbGpPWpGaD
Irbesartan—Fatigue—Dactinomycin—germ cell cancer	0.000222	0.0017	CcSEcCtD
Irbesartan—JUN—BDNF signaling pathway—ALPL—germ cell cancer	0.000221	0.00867	CbGpPWpGaD
Irbesartan—Hypotension—Ifosfamide—germ cell cancer	0.00022	0.00169	CcSEcCtD
Irbesartan—Pain—Dactinomycin—germ cell cancer	0.00022	0.00168	CcSEcCtD
Irbesartan—Muscle spasms—Etoposide—germ cell cancer	0.000219	0.00168	CcSEcCtD
Irbesartan—Urticaria—Bleomycin—germ cell cancer	0.000219	0.00168	CcSEcCtD
Irbesartan—Body temperature increased—Bleomycin—germ cell cancer	0.000218	0.00167	CcSEcCtD
Irbesartan—Dizziness—Vinblastine—germ cell cancer	0.000216	0.00165	CcSEcCtD
Irbesartan—Mood swings—Methotrexate—germ cell cancer	0.000215	0.00165	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000215	0.00164	CcSEcCtD
Irbesartan—JUN—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000214	0.0084	CbGpPWpGaD
Irbesartan—AGTR1—G alpha (q) signalling events—OXT—germ cell cancer	0.000213	0.00836	CbGpPWpGaD
Irbesartan—Myalgia—Cisplatin—germ cell cancer	0.000212	0.00162	CcSEcCtD
Irbesartan—Feeling abnormal—Dactinomycin—germ cell cancer	0.000212	0.00162	CcSEcCtD
Irbesartan—Paraesthesia—Ifosfamide—germ cell cancer	0.000211	0.00162	CcSEcCtD
Irbesartan—Ill-defined disorder—Etoposide—germ cell cancer	0.000211	0.00162	CcSEcCtD
Irbesartan—Anxiety—Cisplatin—germ cell cancer	0.000211	0.00162	CcSEcCtD
Irbesartan—Anaemia—Etoposide—germ cell cancer	0.000211	0.00161	CcSEcCtD
Irbesartan—AGTR1—Peptide ligand-binding receptors—OXT—germ cell cancer	0.00021	0.00825	CbGpPWpGaD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00021	0.00161	CcSEcCtD
Irbesartan—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00021	0.00161	CcSEcCtD
Irbesartan—Dyspnoea—Ifosfamide—germ cell cancer	0.00021	0.00161	CcSEcCtD
Irbesartan—Somnolence—Ifosfamide—germ cell cancer	0.000209	0.0016	CcSEcCtD
Irbesartan—Liver function test abnormal—Methotrexate—germ cell cancer	0.000209	0.0016	CcSEcCtD
Irbesartan—Discomfort—Cisplatin—germ cell cancer	0.000209	0.0016	CcSEcCtD
Irbesartan—Vomiting—Vinblastine—germ cell cancer	0.000207	0.00159	CcSEcCtD
Irbesartan—CYP2D6—female gonad—germ cell cancer	0.000207	0.00233	CbGeAlD
Irbesartan—CYP2C8—brain—germ cell cancer	0.000206	0.00232	CbGeAlD
Irbesartan—Malaise—Etoposide—germ cell cancer	0.000205	0.00157	CcSEcCtD
Irbesartan—Breast disorder—Methotrexate—germ cell cancer	0.000205	0.00157	CcSEcCtD
Irbesartan—Vertigo—Etoposide—germ cell cancer	0.000205	0.00157	CcSEcCtD
Irbesartan—Decreased appetite—Ifosfamide—germ cell cancer	0.000205	0.00157	CcSEcCtD
Irbesartan—Headache—Vinblastine—germ cell cancer	0.000204	0.00157	CcSEcCtD
Irbesartan—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000204	0.00156	CcSEcCtD
Irbesartan—Leukopenia—Etoposide—germ cell cancer	0.000204	0.00156	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000203	0.00156	CcSEcCtD
Irbesartan—Body temperature increased—Dactinomycin—germ cell cancer	0.000203	0.00156	CcSEcCtD
Irbesartan—Abdominal pain—Dactinomycin—germ cell cancer	0.000203	0.00156	CcSEcCtD
Irbesartan—Fatigue—Ifosfamide—germ cell cancer	0.000203	0.00156	CcSEcCtD
Irbesartan—Anaphylactic shock—Cisplatin—germ cell cancer	0.000203	0.00156	CcSEcCtD
Irbesartan—Oedema—Cisplatin—germ cell cancer	0.000203	0.00156	CcSEcCtD
Irbesartan—Hypersensitivity—Bleomycin—germ cell cancer	0.000203	0.00156	CcSEcCtD
Irbesartan—Infection—Cisplatin—germ cell cancer	0.000202	0.00155	CcSEcCtD
Irbesartan—Constipation—Ifosfamide—germ cell cancer	0.000201	0.00154	CcSEcCtD
Irbesartan—Pain—Ifosfamide—germ cell cancer	0.000201	0.00154	CcSEcCtD
Irbesartan—Loss of consciousness—Etoposide—germ cell cancer	0.0002	0.00153	CcSEcCtD
Irbesartan—Nervous system disorder—Cisplatin—germ cell cancer	0.000199	0.00153	CcSEcCtD
Irbesartan—Cough—Etoposide—germ cell cancer	0.000199	0.00152	CcSEcCtD
Irbesartan—Thrombocytopenia—Cisplatin—germ cell cancer	0.000199	0.00152	CcSEcCtD
Irbesartan—Tachycardia—Cisplatin—germ cell cancer	0.000198	0.00152	CcSEcCtD
Irbesartan—Asthenia—Bleomycin—germ cell cancer	0.000198	0.00151	CcSEcCtD
Irbesartan—Skin disorder—Cisplatin—germ cell cancer	0.000197	0.00151	CcSEcCtD
Irbesartan—Hypertension—Etoposide—germ cell cancer	0.000197	0.00151	CcSEcCtD
Irbesartan—Hyperhidrosis—Cisplatin—germ cell cancer	0.000196	0.0015	CcSEcCtD
Irbesartan—Asthma—Methotrexate—germ cell cancer	0.000196	0.0015	CcSEcCtD
Irbesartan—CYP3A4—endocrine gland—germ cell cancer	0.000195	0.0022	CbGeAlD
Irbesartan—Pruritus—Bleomycin—germ cell cancer	0.000195	0.00149	CcSEcCtD
Irbesartan—Feeling abnormal—Ifosfamide—germ cell cancer	0.000194	0.00149	CcSEcCtD
Irbesartan—Chest pain—Etoposide—germ cell cancer	0.000194	0.00149	CcSEcCtD
Irbesartan—Nausea—Vinblastine—germ cell cancer	0.000194	0.00148	CcSEcCtD
Irbesartan—Anorexia—Cisplatin—germ cell cancer	0.000193	0.00148	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000193	0.00148	CcSEcCtD
Irbesartan—JUN—Senescence-Associated Secretory Phenotype (SASP)—H2AFZ—germ cell cancer	0.000193	0.00755	CbGpPWpGaD
Irbesartan—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000193	0.00148	CcSEcCtD
Irbesartan—CYP2D6—endocrine gland—germ cell cancer	0.000192	0.00216	CbGeAlD
Irbesartan—Pancreatitis—Methotrexate—germ cell cancer	0.000192	0.00147	CcSEcCtD
Irbesartan—Discomfort—Etoposide—germ cell cancer	0.000192	0.00147	CcSEcCtD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	0.000191	0.00748	CbGpPWpGaD
Irbesartan—CYP2D6—head—germ cell cancer	0.00019	0.00214	CbGeAlD
Irbesartan—Hypotension—Cisplatin—germ cell cancer	0.00019	0.00145	CcSEcCtD
Irbesartan—Hypersensitivity—Dactinomycin—germ cell cancer	0.000189	0.00145	CcSEcCtD
Irbesartan—Urticaria—Ifosfamide—germ cell cancer	0.000187	0.00143	CcSEcCtD
Irbesartan—EDNRA—G alpha (q) signalling events—AVP—germ cell cancer	0.000186	0.0073	CbGpPWpGaD
Irbesartan—Abdominal pain—Ifosfamide—germ cell cancer	0.000186	0.00143	CcSEcCtD
Irbesartan—Body temperature increased—Ifosfamide—germ cell cancer	0.000186	0.00143	CcSEcCtD
Irbesartan—Anaphylactic shock—Etoposide—germ cell cancer	0.000186	0.00142	CcSEcCtD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—OXT—germ cell cancer	0.000185	0.00726	CbGpPWpGaD
Irbesartan—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000185	0.00142	CcSEcCtD
Irbesartan—Infection—Etoposide—germ cell cancer	0.000185	0.00142	CcSEcCtD
Irbesartan—Asthenia—Dactinomycin—germ cell cancer	0.000184	0.00141	CcSEcCtD
Irbesartan—EDNRA—Peptide ligand-binding receptors—AVP—germ cell cancer	0.000184	0.00721	CbGpPWpGaD
Irbesartan—CYP2D6—testis—germ cell cancer	0.000183	0.00206	CbGeAlD
Irbesartan—Neutropenia—Methotrexate—germ cell cancer	0.000183	0.0014	CcSEcCtD
Irbesartan—Paraesthesia—Cisplatin—germ cell cancer	0.000182	0.0014	CcSEcCtD
Irbesartan—Thrombocytopenia—Etoposide—germ cell cancer	0.000182	0.0014	CcSEcCtD
Irbesartan—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000182	0.00139	CcSEcCtD
Irbesartan—Tachycardia—Etoposide—germ cell cancer	0.000181	0.00139	CcSEcCtD
Irbesartan—Dyspnoea—Cisplatin—germ cell cancer	0.000181	0.00139	CcSEcCtD
Irbesartan—Skin disorder—Etoposide—germ cell cancer	0.000181	0.00138	CcSEcCtD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.00018	0.00706	CbGpPWpGaD
Irbesartan—Hyperhidrosis—Etoposide—germ cell cancer	0.00018	0.00138	CcSEcCtD
Irbesartan—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000179	0.00137	CcSEcCtD
Irbesartan—Anorexia—Etoposide—germ cell cancer	0.000177	0.00136	CcSEcCtD
Irbesartan—Decreased appetite—Cisplatin—germ cell cancer	0.000176	0.00135	CcSEcCtD
Irbesartan—Diarrhoea—Dactinomycin—germ cell cancer	0.000176	0.00135	CcSEcCtD
Irbesartan—Pneumonia—Methotrexate—germ cell cancer	0.000176	0.00135	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000175	0.00134	CcSEcCtD
Irbesartan—Vomiting—Bleomycin—germ cell cancer	0.000175	0.00134	CcSEcCtD
Irbesartan—JUN—Oxidative Stress Induced Senescence—H2AFZ—germ cell cancer	0.000174	0.00683	CbGpPWpGaD
Irbesartan—Hypotension—Etoposide—germ cell cancer	0.000174	0.00133	CcSEcCtD
Irbesartan—Rash—Bleomycin—germ cell cancer	0.000174	0.00133	CcSEcCtD
Irbesartan—Pain—Cisplatin—germ cell cancer	0.000174	0.00133	CcSEcCtD
Irbesartan—Dermatitis—Bleomycin—germ cell cancer	0.000174	0.00133	CcSEcCtD
Irbesartan—Hypersensitivity—Ifosfamide—germ cell cancer	0.000173	0.00133	CcSEcCtD
Irbesartan—Renal failure—Methotrexate—germ cell cancer	0.000172	0.00132	CcSEcCtD
Irbesartan—Conjunctivitis—Methotrexate—germ cell cancer	0.00017	0.0013	CcSEcCtD
Irbesartan—CYP2D6—cerebellum—germ cell cancer	0.000169	0.00191	CbGeAlD
Irbesartan—Asthenia—Ifosfamide—germ cell cancer	0.000169	0.00129	CcSEcCtD
Irbesartan—PTGS1—brain—germ cell cancer	0.000167	0.00188	CbGeAlD
Irbesartan—Feeling abnormal—Cisplatin—germ cell cancer	0.000167	0.00128	CcSEcCtD
Irbesartan—Paraesthesia—Etoposide—germ cell cancer	0.000167	0.00128	CcSEcCtD
Irbesartan—Pruritus—Ifosfamide—germ cell cancer	0.000167	0.00128	CcSEcCtD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	0.000167	0.00653	CbGpPWpGaD
Irbesartan—Dyspnoea—Etoposide—germ cell cancer	0.000166	0.00127	CcSEcCtD
Irbesartan—Somnolence—Etoposide—germ cell cancer	0.000165	0.00127	CcSEcCtD
Irbesartan—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000165	0.00127	CcSEcCtD
Irbesartan—Epistaxis—Methotrexate—germ cell cancer	0.000165	0.00126	CcSEcCtD
Irbesartan—Nausea—Bleomycin—germ cell cancer	0.000164	0.00125	CcSEcCtD
Irbesartan—Vomiting—Dactinomycin—germ cell cancer	0.000163	0.00125	CcSEcCtD
Irbesartan—Agranulocytosis—Methotrexate—germ cell cancer	0.000163	0.00125	CcSEcCtD
Irbesartan—Rash—Dactinomycin—germ cell cancer	0.000162	0.00124	CcSEcCtD
Irbesartan—PTGS1—lymph node—germ cell cancer	0.000162	0.00182	CbGeAlD
Irbesartan—Decreased appetite—Etoposide—germ cell cancer	0.000162	0.00124	CcSEcCtD
Irbesartan—Diarrhoea—Ifosfamide—germ cell cancer	0.000161	0.00123	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000161	0.00123	CcSEcCtD
Irbesartan—Body temperature increased—Cisplatin—germ cell cancer	0.00016	0.00123	CcSEcCtD
Irbesartan—Fatigue—Etoposide—germ cell cancer	0.00016	0.00123	CcSEcCtD
Irbesartan—Pain—Etoposide—germ cell cancer	0.000159	0.00122	CcSEcCtD
Irbesartan—Constipation—Etoposide—germ cell cancer	0.000159	0.00122	CcSEcCtD
Irbesartan—Hepatitis—Methotrexate—germ cell cancer	0.000157	0.0012	CcSEcCtD
Irbesartan—JUN—CD40/CD40L signaling—MYC—germ cell cancer	0.000157	0.00614	CbGpPWpGaD
Irbesartan—Dizziness—Ifosfamide—germ cell cancer	0.000156	0.00119	CcSEcCtD
Irbesartan—Pharyngitis—Methotrexate—germ cell cancer	0.000156	0.00119	CcSEcCtD
Irbesartan—Urinary tract disorder—Methotrexate—germ cell cancer	0.000155	0.00119	CcSEcCtD
Irbesartan—Urethral disorder—Methotrexate—germ cell cancer	0.000154	0.00118	CcSEcCtD
Irbesartan—Feeling abnormal—Etoposide—germ cell cancer	0.000153	0.00117	CcSEcCtD
Irbesartan—JUN—Pre-NOTCH Transcription and Translation—TP53—germ cell cancer	0.000153	0.006	CbGpPWpGaD
Irbesartan—Nausea—Dactinomycin—germ cell cancer	0.000153	0.00117	CcSEcCtD
Irbesartan—Gastrointestinal pain—Etoposide—germ cell cancer	0.000152	0.00117	CcSEcCtD
Irbesartan—Visual impairment—Methotrexate—germ cell cancer	0.000151	0.00116	CcSEcCtD
Irbesartan—Vomiting—Ifosfamide—germ cell cancer	0.00015	0.00115	CcSEcCtD
Irbesartan—Hypersensitivity—Cisplatin—germ cell cancer	0.00015	0.00115	CcSEcCtD
Irbesartan—Rash—Ifosfamide—germ cell cancer	0.000148	0.00114	CcSEcCtD
Irbesartan—Dermatitis—Ifosfamide—germ cell cancer	0.000148	0.00114	CcSEcCtD
Irbesartan—JUN—MAPK Signaling Pathway—FGF4—germ cell cancer	0.000148	0.00581	CbGpPWpGaD
Irbesartan—Urticaria—Etoposide—germ cell cancer	0.000148	0.00113	CcSEcCtD
Irbesartan—Abdominal pain—Etoposide—germ cell cancer	0.000147	0.00113	CcSEcCtD
Irbesartan—Body temperature increased—Etoposide—germ cell cancer	0.000147	0.00113	CcSEcCtD
Irbesartan—JUN—MAPK Cascade—HRAS—germ cell cancer	0.000146	0.00574	CbGpPWpGaD
Irbesartan—Tinnitus—Methotrexate—germ cell cancer	0.000146	0.00112	CcSEcCtD
Irbesartan—AGTR1—G alpha (q) signalling events—AVP—germ cell cancer	0.000146	0.00573	CbGpPWpGaD
Irbesartan—Asthenia—Cisplatin—germ cell cancer	0.000146	0.00112	CcSEcCtD
Irbesartan—Cardiac disorder—Methotrexate—germ cell cancer	0.000145	0.00111	CcSEcCtD
Irbesartan—AGTR1—Peptide ligand-binding receptors—AVP—germ cell cancer	0.000144	0.00566	CbGpPWpGaD
Irbesartan—JUN—IL-5 Signaling Pathway—MYC—germ cell cancer	0.000144	0.00565	CbGpPWpGaD
Irbesartan—Angiopathy—Methotrexate—germ cell cancer	0.000142	0.00109	CcSEcCtD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—FGF4—germ cell cancer	0.000142	0.00557	CbGpPWpGaD
Irbesartan—Immune system disorder—Methotrexate—germ cell cancer	0.000142	0.00109	CcSEcCtD
Irbesartan—Mediastinal disorder—Methotrexate—germ cell cancer	0.000141	0.00108	CcSEcCtD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000141	0.00554	CbGpPWpGaD
Irbesartan—Chills—Methotrexate—germ cell cancer	0.000141	0.00108	CcSEcCtD
Irbesartan—Nausea—Ifosfamide—germ cell cancer	0.00014	0.00107	CcSEcCtD
Irbesartan—Diarrhoea—Cisplatin—germ cell cancer	0.000139	0.00106	CcSEcCtD
Irbesartan—JUN—IL-2 Signaling Pathway—MYC—germ cell cancer	0.000138	0.00543	CbGpPWpGaD
Irbesartan—CYP2D6—brain—germ cell cancer	0.000138	0.00155	CbGeAlD
Irbesartan—EDNRA—GPCR ligand binding—OXT—germ cell cancer	0.000137	0.00537	CbGpPWpGaD
Irbesartan—Hypersensitivity—Etoposide—germ cell cancer	0.000137	0.00105	CcSEcCtD
Irbesartan—Erythema—Methotrexate—germ cell cancer	0.000136	0.00105	CcSEcCtD
Irbesartan—Malnutrition—Methotrexate—germ cell cancer	0.000136	0.00105	CcSEcCtD
Irbesartan—EDNRA—Endothelins—HRAS—germ cell cancer	0.000134	0.00526	CbGpPWpGaD
Irbesartan—Dysgeusia—Methotrexate—germ cell cancer	0.000134	0.00102	CcSEcCtD
Irbesartan—Asthenia—Etoposide—germ cell cancer	0.000133	0.00102	CcSEcCtD
Irbesartan—JUN—Signaling mediated by p38-alpha and p38-beta—TP53—germ cell cancer	0.000132	0.00516	CbGpPWpGaD
Irbesartan—Pruritus—Etoposide—germ cell cancer	0.000132	0.00101	CcSEcCtD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	0.000131	0.00512	CbGpPWpGaD
Irbesartan—Vomiting—Cisplatin—germ cell cancer	0.000129	0.000989	CcSEcCtD
Irbesartan—JUN—Signaling of Hepatocyte Growth Factor Receptor—HRAS—germ cell cancer	0.000129	0.00505	CbGpPWpGaD
Irbesartan—JUN—Presenilin action in Notch and Wnt signaling—MYC—germ cell cancer	0.000129	0.00505	CbGpPWpGaD
Irbesartan—Vision blurred—Methotrexate—germ cell cancer	0.000129	0.000986	CcSEcCtD
Irbesartan—Rash—Cisplatin—germ cell cancer	0.000128	0.000981	CcSEcCtD
Irbesartan—Dermatitis—Cisplatin—germ cell cancer	0.000128	0.00098	CcSEcCtD
Irbesartan—Diarrhoea—Etoposide—germ cell cancer	0.000127	0.000975	CcSEcCtD
Irbesartan—Ill-defined disorder—Methotrexate—germ cell cancer	0.000127	0.00097	CcSEcCtD
Irbesartan—JUN—IL6-mediated signaling events—MYC—germ cell cancer	0.000127	0.00496	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000126	0.00495	CbGpPWpGaD
Irbesartan—Anaemia—Methotrexate—germ cell cancer	0.000126	0.000967	CcSEcCtD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000123	0.00484	CbGpPWpGaD
Irbesartan—Malaise—Methotrexate—germ cell cancer	0.000123	0.000943	CcSEcCtD
Irbesartan—Dizziness—Etoposide—germ cell cancer	0.000123	0.000942	CcSEcCtD
Irbesartan—Vertigo—Methotrexate—germ cell cancer	0.000123	0.00094	CcSEcCtD
Irbesartan—Leukopenia—Methotrexate—germ cell cancer	0.000122	0.000936	CcSEcCtD
Irbesartan—JUN—Cellular Senescence—H2AFZ—germ cell cancer	0.000122	0.00478	CbGpPWpGaD
Irbesartan—Nausea—Cisplatin—germ cell cancer	0.000121	0.000924	CcSEcCtD
Irbesartan—Cough—Methotrexate—germ cell cancer	0.000119	0.000913	CcSEcCtD
Irbesartan—JUN—ATM Signaling Pathway—TP53—germ cell cancer	0.000118	0.00464	CbGpPWpGaD
Irbesartan—Vomiting—Etoposide—germ cell cancer	0.000118	0.000906	CcSEcCtD
Irbesartan—Rash—Etoposide—germ cell cancer	0.000117	0.000898	CcSEcCtD
Irbesartan—Dermatitis—Etoposide—germ cell cancer	0.000117	0.000898	CcSEcCtD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—KITLG—germ cell cancer	0.000117	0.00458	CbGpPWpGaD
Irbesartan—Headache—Etoposide—germ cell cancer	0.000116	0.000893	CcSEcCtD
Irbesartan—Chest pain—Methotrexate—germ cell cancer	0.000116	0.00089	CcSEcCtD
Irbesartan—Myalgia—Methotrexate—germ cell cancer	0.000116	0.00089	CcSEcCtD
Irbesartan—Arthralgia—Methotrexate—germ cell cancer	0.000116	0.00089	CcSEcCtD
Irbesartan—JUN—PDGF Pathway—HRAS—germ cell cancer	0.000115	0.00453	CbGpPWpGaD
Irbesartan—JUN—Signaling events regulated by Ret tyrosine kinase—HRAS—germ cell cancer	0.000115	0.00453	CbGpPWpGaD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000115	0.000884	CcSEcCtD
Irbesartan—Discomfort—Methotrexate—germ cell cancer	0.000115	0.00088	CcSEcCtD
Irbesartan—JUN—ErbB Signaling Pathway—MYC—germ cell cancer	0.000113	0.00444	CbGpPWpGaD
Irbesartan—JUN—IL2-mediated signaling events—MYC—germ cell cancer	0.000113	0.00444	CbGpPWpGaD
Irbesartan—Anaphylactic shock—Methotrexate—germ cell cancer	0.000111	0.000854	CcSEcCtD
Irbesartan—JUN—ErbB2/ErbB3 signaling events—HRAS—germ cell cancer	0.000111	0.00435	CbGpPWpGaD
Irbesartan—Infection—Methotrexate—germ cell cancer	0.000111	0.000848	CcSEcCtD
Irbesartan—Nausea—Etoposide—germ cell cancer	0.00011	0.000846	CcSEcCtD
Irbesartan—Nervous system disorder—Methotrexate—germ cell cancer	0.000109	0.000837	CcSEcCtD
Irbesartan—Thrombocytopenia—Methotrexate—germ cell cancer	0.000109	0.000836	CcSEcCtD
Irbesartan—JUN—IL-2 Signaling Pathway—HRAS—germ cell cancer	0.000109	0.00427	CbGpPWpGaD
Irbesartan—Skin disorder—Methotrexate—germ cell cancer	0.000108	0.000829	CcSEcCtD
Irbesartan—Hyperhidrosis—Methotrexate—germ cell cancer	0.000108	0.000825	CcSEcCtD
Irbesartan—JUN—Pre-NOTCH Expression and Processing—TP53—germ cell cancer	0.000108	0.00422	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—OXT—germ cell cancer	0.000108	0.00422	CbGpPWpGaD
Irbesartan—JUN—FCERI mediated MAPK activation—HRAS—germ cell cancer	0.000107	0.00419	CbGpPWpGaD
Irbesartan—Anorexia—Methotrexate—germ cell cancer	0.000106	0.000814	CcSEcCtD
Irbesartan—Hypotension—Methotrexate—germ cell cancer	0.000104	0.000798	CcSEcCtD
Irbesartan—JUN—Circadian rythm related genes—AVP—germ cell cancer	0.000103	0.00404	CbGpPWpGaD
Irbesartan—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000101	0.000778	CcSEcCtD
Irbesartan—Paraesthesia—Methotrexate—germ cell cancer	0.0001	0.000766	CcSEcCtD
Irbesartan—Dyspnoea—Methotrexate—germ cell cancer	9.93e-05	0.000761	CcSEcCtD
Irbesartan—Somnolence—Methotrexate—germ cell cancer	9.9e-05	0.000759	CcSEcCtD
Irbesartan—JUN—Validated nuclear estrogen receptor alpha network—MYC—germ cell cancer	9.89e-05	0.00388	CbGpPWpGaD
Irbesartan—Dyspepsia—Methotrexate—germ cell cancer	9.8e-05	0.000751	CcSEcCtD
Irbesartan—Decreased appetite—Methotrexate—germ cell cancer	9.68e-05	0.000742	CcSEcCtD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	9.68e-05	0.00379	CbGpPWpGaD
Irbesartan—JUN—TSH signaling pathway—MYC—germ cell cancer	9.65e-05	0.00378	CbGpPWpGaD
Irbesartan—Gastrointestinal disorder—Methotrexate—germ cell cancer	9.62e-05	0.000737	CcSEcCtD
Irbesartan—JUN—IL-3 Signaling Pathway—HRAS—germ cell cancer	9.61e-05	0.00377	CbGpPWpGaD
Irbesartan—Fatigue—Methotrexate—germ cell cancer	9.6e-05	0.000736	CcSEcCtD
Irbesartan—JUN—Copper homeostasis—TP53—germ cell cancer	9.59e-05	0.00376	CbGpPWpGaD
Irbesartan—JUN—Wnt Signaling Pathway—MYC—germ cell cancer	9.53e-05	0.00374	CbGpPWpGaD
Irbesartan—Pain—Methotrexate—germ cell cancer	9.52e-05	0.00073	CcSEcCtD
Irbesartan—JUN—Regulation of Telomerase—MYC—germ cell cancer	9.42e-05	0.00369	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—AVP—germ cell cancer	9.39e-05	0.00368	CbGpPWpGaD
Irbesartan—JUN—ErbB Signaling Pathway—TP53—germ cell cancer	9.3e-05	0.00365	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—H2AFZ—germ cell cancer	9.21e-05	0.00361	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—MYC—germ cell cancer	9.2e-05	0.00361	CbGpPWpGaD
Irbesartan—Feeling abnormal—Methotrexate—germ cell cancer	9.18e-05	0.000703	CcSEcCtD
Irbesartan—Gastrointestinal pain—Methotrexate—germ cell cancer	9.11e-05	0.000698	CcSEcCtD
Irbesartan—JUN—IL2-mediated signaling events—HRAS—germ cell cancer	8.9e-05	0.00349	CbGpPWpGaD
Irbesartan—JUN—ErbB Signaling Pathway—HRAS—germ cell cancer	8.9e-05	0.00349	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Receptor Signaling—HRAS—germ cell cancer	8.9e-05	0.00349	CbGpPWpGaD
Irbesartan—Urticaria—Methotrexate—germ cell cancer	8.85e-05	0.000678	CcSEcCtD
Irbesartan—Body temperature increased—Methotrexate—germ cell cancer	8.8e-05	0.000675	CcSEcCtD
Irbesartan—Abdominal pain—Methotrexate—germ cell cancer	8.8e-05	0.000675	CcSEcCtD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—FGFR3—germ cell cancer	8.67e-05	0.0034	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—germ cell cancer	8.27e-05	0.00324	CbGpPWpGaD
Irbesartan—Hypersensitivity—Methotrexate—germ cell cancer	8.21e-05	0.000629	CcSEcCtD
Irbesartan—JUN—Regulation of nuclear SMAD2/3 signaling—MYC—germ cell cancer	8.19e-05	0.00321	CbGpPWpGaD
Irbesartan—JUN—Fc-epsilon receptor I signaling in mast cells—HRAS—germ cell cancer	8.07e-05	0.00316	CbGpPWpGaD
Irbesartan—Asthenia—Methotrexate—germ cell cancer	7.99e-05	0.000612	CcSEcCtD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—KIT—germ cell cancer	7.96e-05	0.00312	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—MYC—germ cell cancer	7.95e-05	0.00312	CbGpPWpGaD
Irbesartan—Pruritus—Methotrexate—germ cell cancer	7.88e-05	0.000604	CcSEcCtD
Irbesartan—JUN—Endothelins—HRAS—germ cell cancer	7.86e-05	0.00308	CbGpPWpGaD
Irbesartan—JUN—LPA receptor mediated events—HRAS—germ cell cancer	7.77e-05	0.00305	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—OXT—germ cell cancer	7.74e-05	0.00304	CbGpPWpGaD
Irbesartan—Diarrhoea—Methotrexate—germ cell cancer	7.62e-05	0.000584	CcSEcCtD
Irbesartan—JUN—Downstream signaling in naïve CD8+ T cells—HRAS—germ cell cancer	7.58e-05	0.00297	CbGpPWpGaD
Irbesartan—JUN—TSH signaling pathway—HRAS—germ cell cancer	7.58e-05	0.00297	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—TP53—germ cell cancer	7.56e-05	0.00296	CbGpPWpGaD
Irbesartan—JUN—BCR signaling pathway—HRAS—germ cell cancer	7.49e-05	0.00294	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—AVP—germ cell cancer	7.37e-05	0.00289	CbGpPWpGaD
Irbesartan—Dizziness—Methotrexate—germ cell cancer	7.37e-05	0.000564	CcSEcCtD
Irbesartan—JUN—CDC42 signaling events—HRAS—germ cell cancer	7.23e-05	0.00283	CbGpPWpGaD
Irbesartan—JUN—B Cell Receptor Signaling Pathway—MYC—germ cell cancer	7.09e-05	0.00278	CbGpPWpGaD
Irbesartan—Vomiting—Methotrexate—germ cell cancer	7.08e-05	0.000543	CcSEcCtD
Irbesartan—EDNRA—Signaling by GPCR—OXT—germ cell cancer	7.03e-05	0.00276	CbGpPWpGaD
Irbesartan—Rash—Methotrexate—germ cell cancer	7.02e-05	0.000538	CcSEcCtD
Irbesartan—Dermatitis—Methotrexate—germ cell cancer	7.02e-05	0.000538	CcSEcCtD
Irbesartan—Headache—Methotrexate—germ cell cancer	6.98e-05	0.000535	CcSEcCtD
Irbesartan—JUN—Wnt Signaling Pathway and Pluripotency—MYC—germ cell cancer	6.81e-05	0.00267	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—TP53—germ cell cancer	6.66e-05	0.00261	CbGpPWpGaD
Irbesartan—Nausea—Methotrexate—germ cell cancer	6.62e-05	0.000507	CcSEcCtD
Irbesartan—JUN—Apoptosis—TP53—germ cell cancer	6.53e-05	0.00256	CbGpPWpGaD
Irbesartan—JUN—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—germ cell cancer	6.5e-05	0.00255	CbGpPWpGaD
Irbesartan—JUN—Signaling by NOTCH—MYC—germ cell cancer	6.46e-05	0.00253	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—MYC—germ cell cancer	6.46e-05	0.00253	CbGpPWpGaD
Irbesartan—JUN—Apoptosis Modulation and Signaling—TP53—germ cell cancer	6.13e-05	0.0024	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—OXT—germ cell cancer	6.08e-05	0.00238	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—HRAS—germ cell cancer	5.91e-05	0.00232	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—HRAS—germ cell cancer	5.81e-05	0.00228	CbGpPWpGaD
Irbesartan—JUN—PDGFR-beta signaling pathway—MYC—germ cell cancer	5.79e-05	0.00227	CbGpPWpGaD
Irbesartan—JUN—Wnt Signaling Pathway and Pluripotency—TP53—germ cell cancer	5.59e-05	0.00219	CbGpPWpGaD
Irbesartan—JUN—B Cell Receptor Signaling Pathway—HRAS—germ cell cancer	5.57e-05	0.00218	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—MYC—germ cell cancer	5.54e-05	0.00217	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—FGF4—germ cell cancer	5.52e-05	0.00216	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—OXT—germ cell cancer	5.52e-05	0.00216	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—TP53—germ cell cancer	5.46e-05	0.00214	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	5.45e-05	0.00214	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—SLC2A3—germ cell cancer	5.36e-05	0.0021	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—AVP—germ cell cancer	5.31e-05	0.00208	CbGpPWpGaD
Irbesartan—JUN—Signaling by NOTCH—TP53—germ cell cancer	5.3e-05	0.00208	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—TP53—germ cell cancer	5.3e-05	0.00208	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—SLC22A3—germ cell cancer	5.28e-05	0.00207	CbGpPWpGaD
Irbesartan—JUN—ErbB1 downstream signaling—HRAS—germ cell cancer	5.23e-05	0.00205	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—HRAS—germ cell cancer	5.23e-05	0.00205	CbGpPWpGaD
Irbesartan—JUN—Immune System—PVRL2—germ cell cancer	5.09e-05	0.002	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—HRAS—germ cell cancer	5.07e-05	0.00199	CbGpPWpGaD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	5.02e-05	0.00197	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—MYC—germ cell cancer	4.98e-05	0.00195	CbGpPWpGaD
Irbesartan—JUN—Oxidative Stress Induced Senescence—TP53—germ cell cancer	4.94e-05	0.00194	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—AVP—germ cell cancer	4.82e-05	0.00189	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—MYC—germ cell cancer	4.57e-05	0.00179	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—TP53—germ cell cancer	4.55e-05	0.00178	CbGpPWpGaD
Irbesartan—JUN—PDGFR-beta signaling pathway—HRAS—germ cell cancer	4.55e-05	0.00178	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—KITLG—germ cell cancer	4.53e-05	0.00178	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—TP53—germ cell cancer	4.34e-05	0.0017	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—CRABP1—germ cell cancer	4.31e-05	0.00169	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—AVP—germ cell cancer	4.16e-05	0.00163	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—OXT—germ cell cancer	4.15e-05	0.00163	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	4.12e-05	0.00162	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—TP53—germ cell cancer	4.09e-05	0.0016	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—HRAS—germ cell cancer	4.06e-05	0.00159	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	4.04e-05	0.00158	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	3.94e-05	0.00155	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—AVP—germ cell cancer	3.78e-05	0.00148	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TP53—germ cell cancer	3.75e-05	0.00147	CbGpPWpGaD
Irbesartan—JUN—Insulin Signaling—HRAS—germ cell cancer	3.73e-05	0.00146	CbGpPWpGaD
Irbesartan—JUN—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	3.69e-05	0.00145	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—FGF4—germ cell cancer	3.55e-05	0.00139	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.52e-05	0.00138	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—TP53—germ cell cancer	3.46e-05	0.00136	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	3.44e-05	0.00135	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	3.39e-05	0.00133	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—FGFR3—germ cell cancer	3.37e-05	0.00132	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—OXT—germ cell cancer	3.26e-05	0.00128	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—HRAS—germ cell cancer	3.25e-05	0.00128	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—TP53—germ cell cancer	3.25e-05	0.00127	CbGpPWpGaD
Irbesartan—JUN—Immune System—FGF4—germ cell cancer	3.21e-05	0.00126	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	3.17e-05	0.00124	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—H2AFZ—germ cell cancer	3.17e-05	0.00124	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—KIT—germ cell cancer	3.09e-05	0.00121	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—SLC2A3—germ cell cancer	3.02e-05	0.00118	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—SLC22A3—germ cell cancer	2.98e-05	0.00117	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—KITLG—germ cell cancer	2.91e-05	0.00114	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.86e-05	0.00112	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—AVP—germ cell cancer	2.85e-05	0.00112	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—FGF4—germ cell cancer	2.78e-05	0.00109	CbGpPWpGaD
Irbesartan—JUN—Immune System—KITLG—germ cell cancer	2.64e-05	0.00104	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—TP53—germ cell cancer	2.61e-05	0.00102	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—H2AFZ—germ cell cancer	2.48e-05	0.000974	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.45e-05	0.00096	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—OXT—germ cell cancer	2.43e-05	0.000955	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CRABP1—germ cell cancer	2.43e-05	0.000951	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—KITLG—germ cell cancer	2.29e-05	0.000896	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—AVP—germ cell cancer	2.23e-05	0.000876	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—FGFR3—germ cell cancer	2.16e-05	0.000849	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—FGF4—germ cell cancer	2.08e-05	0.000815	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—KIT—germ cell cancer	1.99e-05	0.000779	CbGpPWpGaD
Irbesartan—JUN—Immune System—FGFR3—germ cell cancer	1.96e-05	0.00077	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—SLC2A3—germ cell cancer	1.95e-05	0.000765	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—SLC22A3—germ cell cancer	1.92e-05	0.000754	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—H2AFZ—germ cell cancer	1.86e-05	0.000728	CbGpPWpGaD
Irbesartan—JUN—Immune System—KIT—germ cell cancer	1.8e-05	0.000707	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—KITLG—germ cell cancer	1.71e-05	0.00067	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—FGFR3—germ cell cancer	1.7e-05	0.000666	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—AVP—germ cell cancer	1.67e-05	0.000654	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—SLC2A3—germ cell cancer	1.6e-05	0.000628	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—SLC2A3—germ cell cancer	1.59e-05	0.000623	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—SLC22A3—germ cell cancer	1.58e-05	0.000619	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CRABP1—germ cell cancer	1.57e-05	0.000614	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—SLC22A3—germ cell cancer	1.56e-05	0.000613	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—KIT—germ cell cancer	1.56e-05	0.000612	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—HRAS—germ cell cancer	1.45e-05	0.00057	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SLC2A3—germ cell cancer	1.36e-05	0.000532	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—HRAS—germ cell cancer	1.34e-05	0.000524	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SLC22A3—germ cell cancer	1.34e-05	0.000524	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CRABP1—germ cell cancer	1.29e-05	0.000504	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CRABP1—germ cell cancer	1.28e-05	0.0005	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—FGFR3—germ cell cancer	1.27e-05	0.000498	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—KIT—germ cell cancer	1.17e-05	0.000457	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—HRAS—germ cell cancer	1.14e-05	0.000447	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MYC—germ cell cancer	1.09e-05	0.000429	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CRABP1—germ cell cancer	1.09e-05	0.000427	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLC2A3—germ cell cancer	1.05e-05	0.000411	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLC22A3—germ cell cancer	1.03e-05	0.000405	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TP53—germ cell cancer	8.98e-06	0.000352	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HRAS—germ cell cancer	8.59e-06	0.000337	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MYC—germ cell cancer	8.58e-06	0.000337	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CRABP1—germ cell cancer	8.41e-06	0.00033	CbGpPWpGaD
Irbesartan—JUN—Immune System—HRAS—germ cell cancer	7.79e-06	0.000305	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TP53—germ cell cancer	7.05e-06	0.000276	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HRAS—germ cell cancer	6.74e-06	0.000264	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MYC—germ cell cancer	6.41e-06	0.000251	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TP53—germ cell cancer	5.26e-06	0.000206	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HRAS—germ cell cancer	5.04e-06	0.000197	CbGpPWpGaD
